Logo image
The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
Journal article   Open access   Peer reviewed

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease

Nader Makki, Kristina W. Thiel and Francis J. Miller
International journal of molecular sciences, Vol.14(10), pp.20597-20613
10/15/2013
DOI: 10.3390/ijms141020597
PMCID: PMC3821633
PMID: 24132149
url
https://doi.org/10.3390/ijms141020597View
Published (Version of record) Open Access

Abstract

The epidermal growth factor receptor (EGFR) family and its ligands serve as a switchboard for the regulation of multiple cellular processes. While it is clear that EGFR activity is essential for normal cardiac development, its function in the vasculature and its role in cardiovascular disease are only beginning to be elucidated. In the blood vessel, endothelial cells and smooth muscle cells are both a source and a target of EGF-like ligands. Activation of EGFR has been implicated in blood pressure regulation, endothelial dysfunction, neointimal hyperplasia, atherogenesis, and cardiac remodeling. Furthermore, increased circulating EGF-like ligands may mediate accelerated vascular disease associated with chronic inflammation. Although EGFR inhibitors are currently being used clinically for the treatment of cancer, additional studies are necessary to determine whether abrogation of EGFR signaling is a potential strategy for the treatment of cardiovascular disease.
Biochemistry & Molecular Biology Chemistry Chemistry, Multidisciplinary Life Sciences & Biomedicine Physical Sciences Science & Technology

Details

Metrics

130 readers on Mendeley
1 readers on CiteULike
Logo image